Searched for
COLORECTAL CARCINOMA
27 oral microbes linked to 250% higher pancreatic cancer risk in NYU studyNYU researchers identify 27 oral bacteria and fungi that increase pancreatic cancer risk by 250%. Study analyzed 122,000 participants' sali...- 5 fibre-rich foods to reduce cancer risks. Expert says fibre-maxxing helpsWant to reduce cancer risk? Increase fibre intake. Research suggests dietary fibre helps prevent certain cancers, especially colorectal can...
- Joe Biden's health timeline: From brain aneurysms to prostate cancer diagnosis in 2025Joe Biden, 82, is battling an aggressive form of prostate cancer that has spread to his bones. This diagnosis adds to his extensive medical...
- Aurobindo Pharma shares jump 2% after UK arm secures regulatory approval for cancer drugAurobindo Pharma's stock rose after its subsidiary got approval for a cancer drug. CuraTeQ Biologics received the UK's MHRA approval for Be...
- From liver function test to colonoscopy, 7 essential health tests for dads over the age of 50On this Father's Day, gift daddy dearest -the best gift, a complete health checkup!
- Lupin Partners Enzene to roll out biosimilar Cetuximab hereIn July 2009, the US Food and Drug Administration (USFDA) approved Eli Lilly and Merck's cetuximab (Erbitux) for treatment of metastatic co...
- Lupin launches biosimilar cetuximab in pact with EnzeneCetuximab has received approval from the Drug Controller General of India (DCGI) for its effectiveness in treating head and neck cancer
- Biocon Biologics, Viatris receive approval for cancer drugAbevmy is approved for treatment in metastatic colorectal carcinoma, metastatic breast cancer, non small-cell lung carcinoma, glioblastoma,...
- Biocon Biologics, Viatris Inc. get CHMP nod for Abevmy, a biosimilar to AvastinAbevmy is abiosimilar to Roche's Avastin, prescribed for all indications including metastatic colorectal carcinoma, metastatic breast cance...
- US FDA accepts Biocon's cancer drug application for reviewBiocon and Mylan’s proposed biosimilar bevacizumab, a cancer drug, is expected to be the third biosimilar from the partnered portfolio for ...
- Maintain oral health: Painful gums, mouth ulcers can increase risk of liver cancerPoor oral hygiene can also result due to chronic problems like heart disease, stroke and diabetes.
- Roche files for Avastin to treat breast cancer in EuropeSwiss drugmaker Roche has filed its Avastin drug for use in previously untreated advanced breast cancer in Europe, the company said on Mond...
Load More
